Per Lundin

Chief Executive Officer & Co-founder at Evox Therapeutics

Per has over 10 years of experience in advising, founding and leading biotech companies developing ground breaking therapies. Prior to co-founding Evox in 2016, he founded and led a cell therapy company, practiced patent law as a European Patent Attorney and worked in business development and consulting.

Links

Previous companies

Thomson Reuters logo

Org chart